business / news / / The Economic Times
AstraZeneca is planning to sell its 64-acre manufacturing facility in North Bengaluru.
AstraZeneca Pharma India plans to sell its 64-acre North Bengaluru manufacturing facility.
KEY POINTS
- The land sale is part of AstraZeneca's global manufacturing and supply network review.
- Sattva Group, Aurobindo Pharma, and RMZ have been shortlisted as potential buyers.
- AstraZeneca now seeks a full exit, allowing for commercial and residential redevelopment.
COMPANIES
Summarized by Newsio from The Economic Times. How we summarize →